Keyword: immunotherapy


German Merck Licenses Fusion Protein to PDS

10.01.2023 -

Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based...


ABL Inks Immunotherapeutics Pact with KaliVir

19.07.2022 -

US-based ABL, which bills itself as a pure play CDMO specialized in the development and manufacturing of viruses for vaccine candidates, gene and cancer therapies, is...


BioNTech Collaborations Move Beyond Vaccines

13.01.2022 -

Up to now, the name BioNTech has popped up mostly in one breath with Pfizer, the company’s US partner in developing the mRNA-based Covid-19 vaccine marketed as Comirnaty...


AstraZeneca and Transgene Link on Immunotherapy

08.05.2019 - Anglo-Swedish drugmaker AstraZeneca is to collaborate with French biotech Transgene, part of Institut Mérieux, to discover and develop immunotherapies for treating cancers and...


Eli Lilly and Nektar Develop Autoimmune Therapy

31.07.2017 - US pharma companies Eli Lilly and Nektar Therapeutics have signed an agreement to jointly develop the latter’s novel immunotherapy, NKTR-358, which could potentially treat a number...


US Merck Halts Trial Enrollment After Deaths

14.06.2017 - US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...


FDA Halts Cancer Trial After Deaths

14.07.2016 - The US Food and Drug Administration has ordered Juno Therapeutics to suspend its Phase II immunotherapy trials with adult patients suffering from relapsed or refractory B cell...


New Immunotherapy Coalition Launched in US

13.01.2016 - Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...